Sofinnova Investments, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$32,457,356
+107.9%
2,045,202
+147.2%
2.05%
+100.1%
Q2 2023$15,611,491
+111.2%
827,318
-57.0%
1.02%
+116.3%
Q1 2023$7,390,203
-11.6%
1,924,532
+14.1%
0.47%
-4.6%
Q4 2022$8,363,324
+248.3%
1,686,154
+235.6%
0.50%
+254.3%
Q3 2022$2,401,000
-53.2%
502,393
-56.0%
0.14%
-67.3%
Q2 2022$5,134,000
-24.5%
1,140,788
-20.1%
0.43%
-17.1%
Q1 2022$6,798,000
-47.6%
1,428,169
-18.4%
0.52%
-31.9%
Q4 2021$12,984,000
+3098.0%
1,749,882
+1066.6%
0.76%
+1843.6%
Q1 2019$406,000
-81.1%
150,000
-66.4%
0.04%
-85.4%
Q4 2018$2,146,000447,0750.27%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders